Comparison
Caffeine vs Yohimbine
Caffeine
The most widely consumed psychoactive substance in human history — roughly 80% of the global population uses it daily, mostly via coffee and tea. A competitive adenosine receptor antagonist that lifts the brake on dopamine and norepinephrine signalling. The canonical pairing is 100 mg caffeine + 200 mg L-theanine for clean focus without the jitter.
Yohimbine
Alkaloid from Pausinystalia yohimbe bark. Alpha-2 adrenergic antagonist. Increases norepinephrine. Used for fat loss, libido, and acute focus.
| Field | Caffeine | Yohimbine |
|---|---|---|
| Category | stimulant | stimulant |
| Dose range | 50–400mg | 2.5–10mg |
| Half-life | 5h | 0.5h |
| Onset | 30min | 20min |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●○ | ●●○○○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 25000 | 720 |
The comparison in plain English
Auto-generated from dataCaffeine and Yohimbine are both in the stimulant category respectively. Caffeine The most widely consumed psychoactive substance in human history — roughly 80% of the global population uses it daily, mostly via coffee and tea. Yohimbine Alkaloid from Pausinystalia yohimbe bark.
Bottom line
Caffeine (evidence A, safety 4/5) has a weaker evidence base than Yohimbine (evidence B, safety 2/5). Caffeine has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Caffeine if
Caffeine is the better fit when your goal aligns with its mechanism (Competitively blocks adenosine A1 and A2A receptors) and the dose range (50–400mg) suits your protocol. Half-life is 5h.
Choose Yohimbine if
Yohimbine is the better fit when your goal aligns with its mechanism (Alpha-2 adrenergic receptor antagonist) and the dose range (2.5–10mg) suits your protocol. Half-life is 0.5h.